Triple-negative breast cancer is more aggressive than other forms. It’s more likely to have spread beyond your breast at the time it’s found, and there’s a higher chance it will come back within the first 3 years after treatment. It’s also more likely to be fatal within the first ...
[translate] aTriple negative breast cancer: adjuvant chemotherapy effect on survival. 三倍消极乳腺癌: 辅药化疗作用对生存。[translate]
Triple negative breast cancer confers higher recurrence rates after breast conserving therapy[J].International Journal of Radiation Oncology,Biology,Physics,2008,(01):S153.TriPle negative breast cancer confers higher recurrence rates after breast conserving theraPy. Zaky SS,Lund M,May KA, et al. Int...
The 5-year disease-free survival (DFS) for the entire group was 68.2% and the 5-year overall survival (OS) was 74.5%. We found a pattern of high recurrence rate in the first 3 years following the diagnosis and a clear decline in recurrence rate over the next 3 years. In the ...
To find metastatic recurrence biomarkers of triple-negative breast cancer (TNBC) treated by neoadjuvant chemotherapy and anti-EGFR antibodies (NAT), we evaluated tumor genomic, transcriptomic, and immune features, using MSK-IMPACT assay, gene arrays, Nan
Triple-Negative Breast Cancer by Ethnicity Black women are more likely than any other racial/ethnic group to die of breast cancer.3There are significant disparities in diagnosis, treatment, and survival among racial and ethnic groups. More studies are needed to explore factors like tumor biology an...
and patients' tumors were stages 1, 2 or 3, but not stage 4, meaning they had not yet spread to other parts of the body. In a follow-up 3½ years later, 3,276 patients had died frombreastcancer. The five-year survival rate was about 77% for African American women and about 83...
survival.In the patients with local recurrence,multi-modal therapy(MMT)had 53.0%post-recurrence 3-year survival rate compared with 11.4% of SMT(P=0.024).Similar results were also found in the patients with distant metastases(post-recurrence 3-year survival rate 58.1%for MMT versus29.3%for SMT,...
S2D). Overall, the mRNA and protein expressions of PNPLA8 and LPCAT4 were consistently dysregulated in the tested panel of breast cancer cell lines, and both gene expression levels were correlated with relapse-free survival in breast cancer patients. Fig. 3 PNPLA8 expression levels in breast ...
SurvivalTo determine the incidence, characteristics, and survival outcomes of triple-negative breast cancer patients in a medical oncology practice in Lebanon.The pathology reports of all breast cancer cases diagnosed or treated in 1997-2008 were reviewed.One hundred seventy breast cancer cases (9.3%)...